Article
[Explosive growth of uterine leiomyomas and carcinologic ovarian risk in a non-menopausal patient with BRCA1-BRCA2 mutation treated by tamoxifen].
Journal de gynecologie, obstetrique et biologie de la reproduction - 1 Nov 2002
Doridot V, This P, Clough K B
Abstract excerpt
OBJECTIVE: To report the case of significant growth of a myoma in a premenopausal woman with a suspicion of BRCA1 and BRCA2 mutation, treated by tamoxifen for a hormonodependent breast cancer and to point out the carcinologic ovarian risks with a mutation BRCA1-BRCA2 in this context. Case. Four months after surgical treatment, chemotherapy and the beginning of tamoxifen, an explosive growth of the abdomen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
